Recce Pharmaceuticals Ltd
RECEF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | -$17,662 | -$13,077 | -$10,986 |
| Dep. & Amort. | $0 | $367 | $217 | $188 |
| Deferred Tax | $0 | $0 | $98 | -$456 |
| Stock-Based Comp. | $0 | $20 | $325 | $256 |
| Change in WC | -$182 | $4,266 | -$152 | $1,532 |
| Other Non-Cash | -$20,260 | $0 | -$98 | $456 |
| Operating Cash Flow | -$20,442 | -$13,009 | -$12,687 | -$9,010 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$26 | -$142 | -$39 | -$40 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$237 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$181 | $0 | $0 | $0 |
| Investing Cash Flow | -$444 | -$142 | -$39 | -$40 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $591 | $5,886 | $2,878 | $0 |
| Stock Issued | $28,350 | $11,146 | $102 | $287 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,022 | -$1,028 | -$275 | -$528 |
| Financing Cash Flow | $26,920 | $16,004 | $2,706 | -$240 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $6,034 | $2,854 | -$10,020 | -$9,291 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,415 | $1,562 | $11,582 | $20,873 |
| End Cash | $10,449 | $4,415 | $1,562 | $11,582 |
| Free Cash Flow | -$20,468 | -$13,151 | -$12,726 | -$9,051 |